Penumbra (NYSE:PEN) EVP Johanna Roberts Sells 600 Shares of Stock

Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts sold 600 shares of the stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $266.98, for a total value of $160,188.00. Following the sale, the executive vice president directly owned 63,657 shares of the company’s stock, valued at approximately $16,995,145.86. This trade represents a 0.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Johanna Roberts also recently made the following trade(s):

• On Wednesday, October 1st, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $249.70, for a total value of $149,820.00.
• On Tuesday, September 2nd, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $270.58, for a total transaction of $162,348.00.

Penumbra Stock Performance

Penumbra stock opened at $280.92 on Thursday. The stock has a market cap of $11.00 billion, a price-to-earnings ratio of 74.71, a PEG ratio of 2.10 and a beta of 0.51. The company has a debt-to-equity ratio of 0.02, a quick ratio of 4.04 and a current ratio of 6.75. The stock’s 50 day simple moving average is $256.31 and its two-hundred day simple moving average is $258.18. Penumbra, Inc. has a fifty-two week low of $221.26 and a fifty-two week high of $310.00.

Penumbra (NYSE:PEN) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.07. The company had revenue of $354.69 million during the quarter, compared to analyst estimates of $340.77 million. Penumbra had a net margin of 11.54% and a return on equity of 11.55%. Penumbra’s quarterly revenue was up 17.8% compared to the same quarter last year. During the same period last year, the business earned $0.85 EPS. Penumbra has set its FY 2025 guidance at EPS. As a group, analysts expect that Penumbra, Inc. will post 3.67 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PEN has been the topic of several research analyst reports. Evercore ISI restated an “outperform” rating and set a $286.00 target price on shares of Penumbra in a research note on Thursday, November 6th. William Blair upgraded shares of Penumbra to a “strong-buy” rating in a research report on Friday, July 18th. Robert W. Baird lifted their target price on shares of Penumbra from $283.00 to $285.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 30th. Wells Fargo & Company set a $290.00 price target on Penumbra in a report on Wednesday, October 1st. Finally, BTIG Research reaffirmed a “buy” rating and issued a $320.00 price objective on shares of Penumbra in a report on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $305.69.

Institutional Investors Weigh In On Penumbra

A number of hedge funds have recently modified their holdings of PEN. Diversify Advisory Services LLC raised its holdings in Penumbra by 17.4% in the 3rd quarter. Diversify Advisory Services LLC now owns 3,678 shares of the company’s stock worth $932,000 after purchasing an additional 546 shares during the period. Barclays PLC raised its stake in shares of Penumbra by 24.0% in the third quarter. Barclays PLC now owns 36,476 shares of the company’s stock worth $9,240,000 after buying an additional 7,055 shares during the period. Orion Porfolio Solutions LLC lifted its position in shares of Penumbra by 7.3% during the 3rd quarter. Orion Porfolio Solutions LLC now owns 1,201 shares of the company’s stock valued at $304,000 after buying an additional 82 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Penumbra by 41.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 296,584 shares of the company’s stock valued at $75,126,000 after acquiring an additional 86,335 shares during the period. Finally, NZS Capital LLC grew its stake in shares of Penumbra by 24.9% during the 3rd quarter. NZS Capital LLC now owns 86,984 shares of the company’s stock valued at $22,035,000 after acquiring an additional 17,355 shares during the period. Institutional investors own 88.88% of the company’s stock.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.